Cediranib Affects Tumor Progression and Survival of Mice Bearing Human Ovarian Carcinoma Xenografts Expressing VEGFC

被引：0
|
作者：
Decio, A. [1 ]
Cesca, M. [2 ]
Scarlato, V. [2 ]
Juergensmeier, J. M. [3 ]
Taraboletti, G. [1 ]
Giavazzi, R. [2 ]
Belotti, D. [1 ]
机构：
[1] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy
[2] Mario Negri Inst Pharmacol Res, Milan, Italy
[3] AstraZeneca, Oncol, Macclesfield, Cheshire, England
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
10.1016/S0959-8049(12)71561-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
940
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [1] Cediranib affects tumor progression and survival of mice bearing patient derived ovarian carcinoma xenografts (EOC-PDX)
    Decio, Alessandra
    Cesca, Marta
    Bizzaro, Francesca
    Belotti, Dorina
    Giavazzi, Raffaella
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Cediranib affects tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts (EOC-PDX)
    Decio, A.
    Cesca, M.
    Bizzaro, F.
    Bani, M. R.
    Belotti, D.
    Giavazzi, R.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S112 - S112
  • [3] A SYNTHETIC MATRIX METALLOPROTEINASE INHIBITOR DECREASES TUMOR BURDEN AND PROLONGS SURVIVAL OF MICE BEARING HUMAN OVARIAN-CARCINOMA XENOGRAFTS
    DAVIES, B
    BROWN, PD
    EAST, N
    CRIMMIN, MJ
    BALKWILL, FR
    CANCER RESEARCH, 1993, 53 (09) : 2087 - 2091
  • [4] Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin
    Alessandra Decio
    Marta Cesca
    Francesca Bizzaro
    Luca Porcu
    Rossana Bettolini
    Paolo Ubezio
    Giulia Taraboletti
    Dorina Belotti
    Raffaella Giavazzi
    Clinical & Experimental Metastasis, 2015, 32 : 647 - 658
  • [5] Cediranib combined with chemotherapy reduces tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts with different responsiveness to cisplatin
    Decio, Alessandra
    Cesca, Marta
    Bizzaro, Francesca
    Porcu, Luca
    Bettolini, Rossana
    Ubezio, Paolo
    Taraboletti, Giulia
    Belotti, Dorina
    Giavazzi, Raffaella
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (07) : 647 - 658
  • [6] Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts
    Staffhorst, Rutger W. H. M.
    van der Born, Kasper
    Erkelens, Caroline A. M.
    Hamelers, Irene H. L.
    Peters, Godefridus J.
    Boven, Epie
    de Kroon, Anton I. P. M.
    ANTI-CANCER DRUGS, 2008, 19 (07) : 721 - 727
  • [7] A SYNTHETIC MATRIX METALLOPROTEINASE INHIBITOR DECREASES TUMOR BURDEN AND PROLONGS SURVIVAL OF MICE BEARING HUMAN OVARIAN-CARCINOMA XENOGRAFTS (VOL 53, PG 2087, 1993)
    DAVIES, B
    CANCER RESEARCH, 1993, 53 (15) : 3652 - 3652
  • [8] KINETICS OF BROMODEOXYURIDINE WASHOUT IN MICE BEARING HUMAN TUMOR XENOGRAFTS
    LAWRENCE, TS
    DAVIS, MA
    CHANG, EY
    STETSON, P
    NORMOLLE, DP
    ENSMINGER, WD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 : 243 - 244
  • [9] Circulating plasma vascular endothelial growth factor in mice bearing human ovarian carcinoma xenograft correlates with tumor progression and response to therapy
    Manenti, L
    Riccardi, E
    Marchini, S
    Naumova, E
    Floriani, I
    Garofalo, A
    Dossi, R
    Marrazzo, E
    Ribatti, D
    Scanziani, E
    Bani, M
    Belotti, D
    Broggini, M
    Giavazzi, R
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (05) : 715 - 725
  • [10] VEGFC Gene Expression Is Associated with Tumor Progression and Disease-Free Survival in Cutaneous Squamous Cell Carcinoma
    Garcia-Perez, Omar
    Melgar-Vilaplana, Leticia
    Sifaoui, Ines
    Smietanska, Aleksandra
    Cordoba-Lanus, Elizabeth
    Fernandez-de-Misa, Ricardo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (01)
12345